NEW YORK, March 1 (GenomeWeb News) - Applied Biosystems and MDS Sciex have signed a collaboration with Phenomenome Discoveries to develop metabolomics-analysis software for certain ABI/MDS Sciex mass spectrometers, ABI said today.
Under the terms of the agreement, Phenomenome will customize its non-targeted metabolomics-analysis software for use on the ABI/MDS Sciex 4000 Q Trap and Q Star XL LC/MS/MS systems. The new software will be compatible with Analyst, the instruments' existing data acquisition software, ABI said.
In addition, Phenomenome will use the mass spec systems in conjunction with its software for internal and external contract research, and will provide feedback regarding the performance of the ABI/MDS Sciex platforms.
Financial terms of the deal were not disclosed.
The announcement follows on the heels of a separate metabolomics collaboration ABI penned recently. As GenomeWeb News reported yesterday, ABI and MDS Sciex will work with Biocrates Lifes Sciences of Innsbruck, Austria, to develop methods and consumables for metabolomics.
Under the agreement, the ABI/MDS Sciex joint venture will provide Biocrates with its QStar LC-MS/MS and API 4,000 Q LC-MS/MS mass spectrometry systems. Biocrates will develop consumables and methods for sample preparation and metabolomics analysis, the partners said in a statement.
ABI will distribute any products resulting from the collaboration. Financial terms of the partnership were not disclosed.